| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |